Jim Joyce, the CEO and co-founder of HealthBeacon PLC (EURONEXT:HBCN), said the company is really proud of its results for 2021, a year in which the number of its injection care management units deployed more than doubled.
“The most exciting thing for us is we’re really starting to crack the US market in a significant way”, Joyce told Proactive in the wake of the company’s first set of results as a publicly listed company.
Listing the company gave it the resources to speed up growth. With 10,187 devices deployed at the end of 2021, “our objective is to get to 100,000 devices by the end of 2023”.